HemOnc Today Current Issue

The following articles appeared in the print edition of HemOnc Today.

Table of Contents

• Steady rise in early-onset colorectal cancer among Blacks calls for renewed outreach Jennifer R. Southall
• Should OTC colorectal cancer screening tests be usual care for young Black individuals? Shikha Jain, MD, FACP; VK Gadi, MD, PhD
• Cold agglutinin disease an ‘underappreciated’ anemia with promising new treatments Catherine M. Broome, MD
• Ushering in the era of precision medicine for AML Amer M. Zeidan, MBBS, MHS
• Income inequality for women in oncology: A long-standing issue made worse by COVID-19 Jennifer Byrne
• Work-life balance is a ‘swinging pendulum’ that requires attention on each side Talitha Bennett
• HSCT significantly improves outcomes among older patients with myelodysplastic syndrome Drew Amorosi
• Mycophenolate reduces treatment failure in immune thrombocytopenia Mark Leiser
• Belumosudil shows promise for chronic GVHD Alexandra (Sasha) Todak
• Ruxolitinib effective as second-line therapy for chronic GVHD Drew Amorosi
• Black race an independent predictor of poor survival among young adults with AML Jennifer R. Southall
• Novel T-cell therapy shows promise to treat COVID-19 in high-risk patients Jennifer R. Southall
• Venetoclax plus ibrutinib may induce treatment-free remission in patients with CLL Jennifer R. Southall
• Genetic mutation predicts poor outcomes in CLL Jennifer R. Southall
• Registry sheds light on vulnerability of patients with hematologic malignancies, COVID-19 Jennifer R. Southall
• IDH mutations linked to cardiotoxicity among adults with AML Jennifer R. Southall
• Some women with early breast cancer may skip adjuvant chemotherapy Mark Leiser
• Symptoms often underrecognized among patients receiving radiotherapy for breast cancer Mark Leiser
• Sacituzumab govitecan effective for triple-negative breast cancer regardless of biomarkers Alexandra (Sasha) Todak
• Mastectomy, reconstructive surgery for breast cancer may increase chronic opioid use Mark Leiser
• Black patients less likely to undergo treatment for colorectal liver metastases Jennifer R. Southall
• Patients may be less likely to enroll on cancer trials during COVID-19 pandemic Jennifer R. Southall
• Long-term active surveillance safe, viable option for certain men with prostate cancer Jennifer R. Southall
• FDA grants priority review, fast track status to several hematology/oncology products
• FDA approves PET imaging drug for prostate cancer
• FDA approves Gavreto for RET-altered thyroid cancers
• FDA grants breakthrough status to IMGN632 for blastic plasmacytoid dendritic cell neoplasm
• FDA grants regulatory designations to PTC596 for sarcoma, glioma subsets
• FDA approves Opdivo-Yervoy combination for malignant pleural mesothelioma
• FDA grants breakthrough therapy status to LNP023 for paroxysmal nocturnal hemoglobinuria
• FDA approves Danyelza for high-risk neuroblastoma
• FDA approves Xpovio as part of combination for pretreated multiple myeloma